Imagine detecting early signs of neurological disorders just by tracking your steps. Researchers at Tel Aviv University have created a groundbreaking wearable sensor that does exactly that.
"A bridge has actually been opened between the groundbreaking scientific research to diagnose the disease and the innovative clinical treatment."
The drug contains an antibody that aims to slow the progression of the incurable Alzheimer’s disease. It operates by eliminating the buildup of amyloid protein plaque in the brain.
Lifestyle medicine prevents and reverses many chronic conditions and even auto-immune ones.
“We discovered that certain metals binding within the matrix can alter its structure, forming complexes that serve as the fundamental units of memory," researchers wrote.
Sarah Goldstein’s fourth book, Now You Are Here: Navigating Nursing Home Care for a Loved One, was specifically written for those caring for a loved one residing in a nursing home.
The new test, considered revolutionary in the field of health sciences, will allow doctors to make faster diagnoses to help patients seek treatments that could slow the development of the disease.
In a scientific breakthrough, a team of researchers from Israel and Italy found potential interventions in the early stages of Alzheimer's and stress targeting this earlier stage.
April Rosenfeld is a dedicated supporter of the Hebrew University.
Two professors at Rutgers University in New Jersey – both of them leading researchers in the field of Alzheimer’s disease (AD) – have partnered with Tel Aviv University (TAU) and Hebrew U.